Spravato

Spravato Treatment.

Barrier Islands Psychiatry offers Spravato Treatment. Spravato is the first FDA-approved nasal spray, indicated for patients with Treatment-Resistant Depression. Spravato targets the NMDA receptor and is believed to drastically reduce depression symptoms.

  1. Therapy sessions are conducted in our office weekly for 8 weeks.
  2. Patients are required to have a ride to and from treatment.
  3. Each treatment session is 2 hours after the medication is given and patients are closely monitored.
  4. If common side effects occur, they usually happen right after the medication is administered and go away the same day.
  5. It’s covered by most health insurance plans, there is also Patient Support through Janssen CarePath for patients who qualify.
Group Therapy psychiatry